Bell2Bell

Bell2Bell-Bell2Bell Podcast featuring Silo Pharma Inc. (OTCQB: SILO) CEO Eric Weisblum

2022 | 9:48 | FINANCE |

Keywords: biopharma, PTSD, therapeutics, psychedelics, Parkinson’s, fibromyalgia, Alzheimer’s, ketamine, psilocybin, Translational Psychedelic Research

Up next

More Episodes


Comments